About GENESIS Pharma

GENESIS Pharma was among the first pharmaceutical companies in Europe specialized in biopharmaceutical products and is currently the largest among Greek companies specializing in innovative medicines. The company has created a strong product portfolio that includes high-tech pharmaceutical products for severe and rare diseases, through long standing strategic alliances for the broader region of Southeast Europe with some of the leading multinational pharmaceutical companies committed to cutting edge R&D.
GENESIS Pharma maintains a wide product portfolio for rare hematological malignancies and threatening cancers, such as multiple myeloma, leukemia, metastatic pancreatic cancer and metastatic breast cancer, while it is considered as one of the most specialized companies in multiple sclerosis in Greece. Its portfolio also includes products in the therapeutic areas of dermatology, rheumatology and nephrology.
For more information please visit